Biomarkers show value of studying dementia in Down syndrome

Nature Reviews Neurology, Published online: 31 August 2021; doi:10.1038/s41582-021-00558-wMore than 90% of people with Down syndrome develop Alzheimer disease but receive little or no treatment for their dementia. Novel biomarkers of ageing and dementia bring new hope to this medically vulnerable population and can also help researchers understand dementia in other populations.
Source: Nature Reviews Neurology - Category: Neurology Authors: Source Type: research